96 related articles for article (PubMed ID: 33640964)
1. DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.
Kato H; Naiki-Ito A; Suzuki S; Inaguma S; Komura M; Nakao K; Naiki T; Kachi K; Kato A; Matsuo Y; Takahashi S
Carcinogenesis; 2021 Jul; 42(7):940-950. PubMed ID: 33640964
[TBL] [Abstract][Full Text] [Related]
2. NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis.
Hu H; Li B; Chen H; Fan G; Ye Z; Ji S; Yu X; Xu X; Qin Y
Mol Carcinog; 2024 Feb; 63(2):195-208. PubMed ID: 37846815
[TBL] [Abstract][Full Text] [Related]
3. Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.
Chen H; Bian A; Yang LF; Yin X; Wang J; Ti C; Miao Y; Peng S; Xu S; Liu M; Qiu WW; Yi Z
Oncogene; 2021 Feb; 40(8):1440-1457. PubMed ID: 33420372
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophages drive glycolysis through the IL-8/STAT3/GLUT3 signaling pathway in pancreatic cancer progression.
Zhong Z; Yang K; Li Y; Zhou S; Yao H; Zhao Y; Huang Y; Zou J; Li Y; Jiajia Li ; Lian G; Huang K; Chen S
Cancer Lett; 2024 Apr; 588():216784. PubMed ID: 38458594
[TBL] [Abstract][Full Text] [Related]
5. TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.
Gore J; Craven KE; Wilson JL; Cote GA; Cheng M; Nguyen HV; Cramer HM; Sherman S; Korc M
Oncotarget; 2015 Apr; 6(10):7504-21. PubMed ID: 25762644
[TBL] [Abstract][Full Text] [Related]
6. Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes.
Dankner M; Maritan SM; Priego N; Kruck G; Nkili-Meyong A; Nadaf J; Zhuang R; Annis MG; Zuo D; Nowakowski A; Biondini M; Kiepas A; Mourcos C; Le P; Charron F; Inglebert Y; Savage P; Théret L; Guiot MC; McKinney RA; Muller WJ; Park M; Valiente M; Petrecca K; Siegel PM
Neuro Oncol; 2024 Jun; 26(6):1052-1066. PubMed ID: 38271182
[TBL] [Abstract][Full Text] [Related]
7. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice.
Teper Y; Ye L; Waldron RT; Lugea A; Sun X; Sinnett-Smith J; Hines OJ; Pandol SJ; Rozengurt E; Eibl G
Sci Rep; 2023 Sep; 13(1):16144. PubMed ID: 37752238
[TBL] [Abstract][Full Text] [Related]
8. Prevention of pancreatic cancer in a hamster model by cAMP decrease.
Banerjee J; Papu John AM; Al-Wadei MH; Schuller HM
Oncotarget; 2016 Jul; 7(28):44430-44441. PubMed ID: 27281617
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled nanomicelles for oral delivery of luteolin utilizing the intestinal lymphatic pathway to target pancreatic cancer.
Karole A; Dinakar YH; Sagar P; Mudavath SL
Nanoscale; 2024 Apr; 16(15):7453-7466. PubMed ID: 38517408
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of luteolin proven by patient-derived organoids of gastric cancer.
Hao X; Zu M; Ning J; Zhou X; Gong Y; Han X; Meng Q; Li D; Ding S
Phytother Res; 2023 Nov; 37(11):5315-5327. PubMed ID: 37469042
[TBL] [Abstract][Full Text] [Related]
11. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
James CA; Baer JM; Zou C; Panni UY; Knolhoff BL; Hogg GD; Kingston NL; Kang LI; Lander VE; Luo J; Tao Y; Watson MA; Aft R; Fields RC; Hawkins WG; DeNardo DG
Cancer Immunol Res; 2023 Aug; 11(8):1055-1067. PubMed ID: 37229629
[TBL] [Abstract][Full Text] [Related]
12. Anti-Proliferative Potential of Cynaroside and Orientin-In Silico (DYRK2) and In Vitro (U87 and Caco-2) Studies.
Pirvu LC; Pintilie L; Albulescu A; Stefaniu A; Neagu G
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068880
[TBL] [Abstract][Full Text] [Related]
13. Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.
Chen H; Bian A; Yang LF; Yin X; Wang J; Ti C; Miao Y; Peng S; Xu S; Liu M; Qiu WW; Yi Z
Oncogene; 2024 Jun; ():. PubMed ID: 38839943
[No Abstract] [Full Text] [Related]
14. Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis.
Li XX; Li H; Jin LQ; Tan YB
Pharmgenomics Pers Med; 2023; 16():467-480. PubMed ID: 37252337
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies.
Park J; Huang D; Chang YJ; Lim MC; Myung SK
Carcinogenesis; 2022 Apr; 43(3):231-242. PubMed ID: 34958358
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
Wang H; Yang B; Cai X; Cheng X; Shen N; Liu L; Li J; Wang Y; He H; Ying P; Li B; Lu Z; Yang N; Wang X; Zhang F; Li Y; Wang W; Ning C; Zhu Y; Chang J; Miao X; Tian J; Zhong R
Carcinogenesis; 2021 Nov; 42(11):1347-1356. PubMed ID: 34665859
[TBL] [Abstract][Full Text] [Related]
17. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer.
Fujisawa R; Iwaya T; Endo F; Idogawa M; Sasaki N; Hiraki H; Tange S; Hirano T; Koizumi Y; Abe M; Takahashi T; Yaegashi M; Akiyama Y; Masuda M; Sasaki A; Takahashi F; Sasaki Y; Tokino T; Nishizuka SS
Carcinogenesis; 2021 Oct; 42(10):1239-1249. PubMed ID: 34559206
[TBL] [Abstract][Full Text] [Related]
18. USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network.
Yoon S; Choi JH; Shah M; Kwon SM; Yang J; Park YN; Wang HJ; Woo HG
Carcinogenesis; 2021 Oct; 42(9):1208-1220. PubMed ID: 34293111
[TBL] [Abstract][Full Text] [Related]
19. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis.
Festa Ortega JF; Heidor R; Auriemo AP; Marques Affonso J; Pereira D' Amico T; Herz C; de Conti A; Ract J; Gioieli LA; Purgatto E; Lamy E; P Pogribny I; Salvador Moreno F
Carcinogenesis; 2021 Aug; 42(8):1026-1036. PubMed ID: 33999989
[TBL] [Abstract][Full Text] [Related]
20. Revisiting luteolin: An updated review on its anticancer potential.
Rauf A; Wilairatana P; Joshi PB; Ahmad Z; Olatunde A; Hafeez N; Hemeg HA; Mubarak MS
Heliyon; 2024 Mar; 10(5):e26701. PubMed ID: 38455556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
